Matthew Provenzano, MD
Pediatric Otolaryngology · Michigan City, INNPI 1639388911
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Advanced Bionics, LLC at 35.9% of the total. Reporting peaked in 2019 at $128 and has fallen 88.9% since, to $14 in 2025.
Across 16 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Advanced Bionics, LLC$127
- Stryker$56
- Smith+Nephew$56
- Acclarent, Inc$47
- Novartis$22
- Amgen$18
- plus $28 from 2 others
What the payments were for
- Food & beverage$355100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Advanced Bionics, LLC | 6 | $127 |
| Stryker | 2 | $56 |
| Smith+Nephew | 2 | $56 |
| Acclarent, Inc | 2 | $47 |
| Novartis | 1 | $22 |
| Amgen | 1 | $18 |
| Cochlear Americas | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
How this compares
Too few pediatric otolaryngology providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 26 | $912 |
| Dexamethasone Sodium Phosphate | 24 | $850 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 16 | $522 |
| Azelastine Hcl | 38 | $436 |
| Montelukast Sodium | 26 | $300 |
| Cefdinir | 16 | $282 |
| Pantoprazole Sodium | 28 | $266 |
| Betamethasone Valerate | 21 | $204 |
| Clindamycin Hcl | 15 | $183 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $156 |
| Mupirocin | 17 | $95 |
| Methylprednisolone | 20 | $76 |
Paid to pharmacies, not to this prescriber.
Other pediatric otolaryngology in Michigan City
- Stacey IshmanIndianapolis$32K
- Matthew PartainIndianapolis$2K
- Bruce MattIndianapolis$997
- Richard MiyamotoIndianapolis$811
- Ravindhra ElluruIndianapolis$377
- Wenhua ChenIndianapolis$360
- Lauren SowaIndianapolis$245
- Ronda HamakerIndianapolis$177
- Dean TriggIndianapolis$65
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.